CRS II PH 45931/62704 |
| CRS II needed to assist clinical trial leader or may act as clinical trial leader in the management ... |
|
Contract Clinical Safety Scientist |
| Contract Clinical Safety Scientist in East Hanover, NJ
Responsible for performing global ... |
|
Sr. CRA/CRA (1 to 2 years experience), Oncology: Industry Leading Northern New Jersey Pharma |
| Sr. CRA/CRA (1 to 2 years experience), Oncology:
Industry Leading Northern New Jersey Pharma
&... |
|
Sr. CRA/CRA (1 to 2 years experience): Industry Leading Northern New Jersey Pharma |
| Sr. CRA/CRA (1 to 2 years experience):
Industry Leading Northern New Jersey Pharma
Our ... |
|
Assistant/Associate Director, Medical Affairs |
| OVERALL RESPONSIBILITY : The primary responsibilities for this position are to manage the ... |
|
Medical Reviewer/Safety Reviewer |
| Responsibilities include medical review, which involves in-house review of Case Report Forms (CRFs) ... |
|
Systems Administrator |
| I. POSITION SUMMARY: The qualified candidate will provide System Administration ... |
|
Associate Directors, Clinical Operations, New Positions NJ Pharma |
| Associate Directors, Clinical Operations, New Positions NJ Pharma
Nutshell Summary: A ... |
|
Senior Systems/Quality Analyst |
| Vaco Technology is looking for a Senior Systems Analyst for a permanent position with a client, in ... |
|
Account Manager - Specialty Food Ingredient |
| Job Summary:
The position applies broad sales and marketing principles to develop, ... |
|
|
Statistical Programmer
| Details |
Country: USA
Location: NJ Jersey City
Total applied: 7
|
|
Statistical Programmer
Statistical Programmer needed for a 6-month renewable contract. Candidate will perform statistical programming in support of the analysis of clinical studies, integrated summaries, and responses to questions from regulatory authorities.
Responsibilities include:
-Perform role of validation programmer on all assigned studies and responses to requests from regulatory authorities.
-Review data definition tables for SDTM and derived data sets for assigned studies and provide comments.
-Review data definition tables for SDTM and derived data sets for assigned partner studies and provide comments.
-Review statistical analysis plans for all assigned studies in conjunction with primary study statistical programmer and provides comments to study biostatistician.
-Review annotated case report forms in conjunction with primary study statistical programmer and provides comments to study database administrator.
-Review edit check specifications in conjunction with primary study statistical programmer and provide comments to study data manager.
-Support direct supervisor and Senior/Director, Statistical Programming.
- Provide leadership with respect to Statistical Programming, BPSS, and CDMA.
Candidate must have 2+ years of statistical programming experience in a pharmaceutical setting, Bachelor's Degree in Statistics, Biostatistics, Epidemiology or Computer Science. Must have experience in Phase III clinical trials, and experience with efficacy and safety ( generating analysis data sets & tables/listings/figures, and experience with ISS/ISE.
Smith Hanley Consulting Group,a division of Smith Hanley, specializes in providing clinical trials staffing to national pharmaceutical companies offering long-term contract services of Statisticians, SAS Programmers, Data Managers, Clinical Research Associates and other clinical specialties. Our professional recruiters are recognized leaders in the industry by placing junior to senior candidates into rewarding positions within leading pharmaceutical companies throughout the United States. For more than twenty years, we have built extensive client relationships. We strive to help our candidates make decisions that are consistent with their professional values, priorities and goals as well as provide our clients with candidates that meet their employment needs.
|
| Related jobs |
|
|
Director, Scientific Affairs
DIRECTOR, SCIENTIFIC AFFAIRS
Barr Pharmaceuticals, Inc. a holding company that operates through its principal subsidiaries, Barr Laboratories, Inc. and Duramed P...
|
|
|
Medical Safety Associate, Global Drug Safety Quality and Compliance
Welcome to Novartis - the company that considers its employees to be its greatest asset.
Good Business.
Great Opportunities.
How do you spend your day? Are you ...
|
|
|
Sr. CRA, Phase IV, in-house, Successful New Jersey Pharma
Profile: A very successful and stable pharmaceutical company is looking for a full-time Sr. CRA to join a team conducting global Phase IV studies on a blockbuster drug ...
|
|
|
Manager, Financial Planning & Analysis
Summary:
Position objectives include providing analysis, forecasting, budgeting and management support to Senior Management. This position will serve as the ...
|
|
|
Clinical /Sr Clinical Research Scientist - USCD&MA CVM (Hypertension)
Welcome to Novartis - the company that considers its employees to be its greatest asset.
Good Business.
Great Opportunities....
|
|
|
Senior Formulation Scientist
As a world leading pharmaceutical and consumer healthcare company, GlaxoSmithKline helps people lead longer, healthier more productive lives. In a fiercely competitive ...
|
|
|
3m Sr CRS II 46067/62470 AT
3M Sr. CRS II needed for a 3-month contract. Candidate will assist clinical trial leader or may act as clinical trial leader in the management of individual clinical ...
|
|
|
Manager of QC Biochemistry in Biologics
Remember when your career dreams were limitless? They can be again when you work with Yoh Scientific. Our customers look to Yoh Scientific to deliver talent with fresh ...
|
|
|
Metrology Supervisor
Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products. Our products and research pipeline harness the power of biology to improve ...
|
|
|
Marketing Manager - Surgical Devices/Implants
Looking to take your marketing career to the next level? Want to work for a company that has a history of high sales growth, internal promotions and development, ...
|
|
| Related press releases |
Rates uncertainty takes its pound of flesh
The worst may be over as far as the over-valuation of the pound is concerned; but the problem for industry is that no one knows how far it will fall - or how long it will...
|
|
Europe raises stakes in rates race
The stakes have been raised in the great global interest rate race. The Europeans have cranked up rates by half a per cent, following the recent lead of the Americans. Br...
|
|
Euro bank ratchets up rates
The European Central Bank yesterday moved to stamp out the threat of increased inflation in the euro zone with an aggressive half point rise in borrowing costs, ignoring ...
|
|
Manufacturing breathes sigh of relief over rates
Hopes that borrowing costs may have reached their peak were raised yesterday after the Bank of England left its key interest rates on hold at 6% for the fourth month in a...
|
|
Unchanged rates lift economic mood
Financial markets are capricious beasts. A couple of months ago, the feeling in the City was that interest rates - which had risen from 5% to 6% during the autumn - were ...
|
|
Interest rates remain at 6%
The Bank of England has left interest rates unchanged at 6% for the fourth month in succession.
The decision, widely expected by City analysts, comes amid signs that th...
|
|
Economy 'growing at above target rate
Interest rates in the UK may not yet have peaked, despite last week's 'no change' decision by the Bank of England's Monetary Policy Committee.
This is the implication o...
|
|
Rates stay steady but fear still grows as communities wait for government lead
Othery, Wrexham and Sheffield are not obvious places to visit for a series on crime. They have not featured in the news recently (not for crime anyway), and they are ne...
|
|
Interest rates set to stand still as inflation eases
The Bank of England's monetary policy committee (MPC) is set to leave interest rates unchanged again at its monthly meeting this week.
New statistics have shown an easi...
|
|
Fed holds rates steady as economy cools
Signs that the American economy is cooling down persuaded the US federal reserve to keep interest rates on hold yesterday.
The decision by the US central bank to keep t...
|
|
|
|